Seeking Alpha

LT

LT
Send Message
View as an RSS Feed
View LT's Comments BY TICKER:
Latest  |  Highest rated
  • QuickChat #248, November 7, Postelection [View instapost]
    For you battery nuts....XIDE misses big time on profit and revenue. Some thought they would have a good quarter.

    4:25 PM Exide (XIDE): FQ2 EPS loss of $0.18 misses by $0.20. Revenue of $712M misses by $41M. (PR) [Earnings] Comment!
    Nov 9 04:53 PM | 2 Likes Like |Link to Comment
  • QuickChat #248, November 7, Postelection [View instapost]
    They knew Wednesday morning that was the deal...the same one "O" & Boehner agreed to before. That's why they jumped on it day one.

    This time...it's either pass what they had, maybe even get a few perks or go off the cliff. It's their choice & they know it. Now let the fun begin. But the Bush tax cuts are gone by Jan.1
    Nov 9 04:05 PM | 2 Likes Like |Link to Comment
  • QuickChat #248, November 7, Postelection [View instapost]
    LOL DrRich ! It's probably true. Most here are just glad it's over, even tho KY went to Romney.

    It will be a hard fought negotiation on the way to a deal, but I am glad they went to work on it day one.
    Nov 9 12:24 PM | 3 Likes Like |Link to Comment
  • QuickChat #248, November 7, Postelection [View instapost]
    Love that last paragraph, and it is so true "the rich get a call" after whatever % drop comes.
    Nov 9 11:22 AM | 4 Likes Like |Link to Comment
  • QuickChat #248, November 7, Postelection [View instapost]
    I agree Joseph....in fact I will say that if played right both sides win and so does the USA. (and both sides may want to as well as need to)
    Nov 9 11:18 AM | 5 Likes Like |Link to Comment
  • QuickChat #248, November 7, Postelection [View instapost]
    There is truth in what you say dg, I wasn't just implying PM's or just politics. I too made money in physical PM's....not enough but got my childs part. I am just afraid to play them now. I still dabble in physical when I find it at a nice discount. Gold got close enough to the $2000 for me to be happy and back away ... gov's are going to use PM's as collateral IMO, but they also can manipulate prices to their advantage. Therefore I tread lightly.

    Politics & the global crisis is what it is...but playing the positives has so far made me more than doom & gloom.
    Nov 9 09:22 AM | 3 Likes Like |Link to Comment
  • QuickChat #248, November 7, Postelection [View instapost]
    I think you are way too negative....Your hatred for one man causes a bias toward anything/any article that has negative doomsday news.

    For every negative (and there are some with merit) I see 10 positives and outweigh the negatives.

    Time will tell, but naysayers have been wrong for 4 years, and IMO they are wrong now.
    Nov 9 09:01 AM | 5 Likes Like |Link to Comment
  • QuickChat #248, November 7, Postelection [View instapost]
    Oversold everywhere....might be a good day for a day trade to the upside
    http://seekingalpha.co...
    Nov 9 07:03 AM | 5 Likes Like |Link to Comment
  • Swine Flu AND Medical News Concentrator October 13, 2012 To December 31, 2012 [View instapost]
    1000 new cases of Hepatitis outbreak in Sudan....What is Hepatitis "E" ? and what drugs work on it? Vertex?

    http://yhoo.it/Teq7hY
    Nov 9 06:09 AM | 3 Likes Like |Link to Comment
  • QuickChat #248, November 7, Postelection [View instapost]
    VIX ... good article
    http://seekingalpha.co...
    Nov 9 05:58 AM | 4 Likes Like |Link to Comment
  • QuickChat #248, November 7, Postelection [View instapost]
    I too would not invest in health insurers....but premiums won't go up as much as some think.
    The "uninsured" will cost them, that is somewhat priced in with the huge premium increases already in place....also, most companies are already over the 20%. I think,, they got admin expense included in the payouts too.
    But, the big one is ..."Walk in Clinics" and Urgent Care clinics...they save up to 80% vs. the Emergency Room.
    An example is ... take a child to the ER (because Dr. office closed) with a fever and runny nose they give Tylenol...cost =$400. Walk in Clinic costs $20-$75.
    These are popping up everywhere...pharmacies like Walgreen, CVS already offer flu shots for $20-25, where the average Dr. visit is now $75.
    Remember I was a Nurse (critical care RN) and the last day I worked the ER at one of our small hospitals in the adjoining county we had a stomach virus (flu) outbreak....people came to the ER that Saturday, with nausea, vomiting, stomach cramps and fever.
    We gave them a bag of IV fluids, IV antibiotic, pain shot, anti-nausea drug and then....Chest X-ray, CT scan of the abdomen, to rule out bowel obstruction....total cost= $4000
    The only thing that helped was IV fluids, antibiotic & phenergan or Zofran for nausea. These were all young strong healthy adults and a few kids.
    We also admitted enough to fill the hospital rooms too.
    Hospitals have used the ER for the last 15 years to fill the hospitals full. "Defensive medicine" they called it. This is where the healthcare costs have skyrocketed.
    Keeping patients out of the ER will save much, much more than the cost of the uninsured and other related costs. IF, you let my team of nurses manage healthcare, we could reduce costs or revenues by 50%.
    The question is..where is hospitals going to get the lost revenue? Baby Boomers will use them as they age, but look for big increases in Hospice care, which is already starting & home health.

    You can google "10 things Health care clinics won't tell you" to the link to MarketWatch.com I think.....

    Nov 8 06:45 PM | 3 Likes Like |Link to Comment
  • Swine Flu AND Medical News Concentrator October 13, 2012 To December 31, 2012 [View instapost]
    There is alot more to the ZGNX earnings release and announcements. I will be buying soon. I think the bottom or close is in today.

    FYI...I started buying more NVAX on this drop. Just taking 1000 share blocks on each dip.
    Nov 8 04:34 PM | 4 Likes Like |Link to Comment
  • Swine Flu AND Medical News Concentrator October 13, 2012 To December 31, 2012 [View instapost]
    SAN DIEGO, Nov. 8, 2012 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company commercializing and developing products for the treatment of central nervous system disorders and pain, today announced that the U.S. Food and Drug Administration's (FDA) Anesthetic and Analgesic Drug Products Advisory Committee (AADPAC) will review the Company's New Drug Application (NDA) for Zohydro ER (hydrocodone bitartrate extended-release capsules) on December 7, 2012. Zohydro ER is Zogenix's lead investigational product candidate for the management of moderate-to-severe chronic pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. Details of the meeting agenda will be available in the Federal Register.
    The Prescription Drug User Fee Act (PDUFA) date for completion of the review by the FDA is March 1, 2013. If approved, Zohydro ER will be classified as a Drug Enforcement Agency (DEA) Schedule II drug, subject to stricter prescribing and dispensing rules compared to the currently prescribed hydrocodone products. Zogenix has included in the NDA a comprehensive Risk Evaluation and Mitigation Strategy (REMS) that is consistent with current FDA and industry-wide guidelines for extended-release opioid products. The REMS is intended to control inappropriate prescribing, misuse and abuse of extended-release opioids while maintaining patient access to essential pain medications.
    Nov 8 04:32 PM | 4 Likes Like |Link to Comment
  • QuickChat #248, November 7, Postelection [View instapost]
    don't forget insurance companies tried to double premiums over a year ago. I doubt they go up much more.
    Nov 8 01:01 PM | 2 Likes Like |Link to Comment
  • Swine Flu AND Medical News Concentrator October 13, 2012 To December 31, 2012 [View instapost]
    Bio-Cryst (BCRX) just had a disaster day.. shows the risk with bio's. I thought this drug was guaranteed. The CDC stockpiled it during the last H1N1 crisis. Thankfully I did not own it. GERN was bad enough.

    9:49 AM BioCryst (BCRX) -41% after ending Phase III trials of its peramivir flu drug, as "the difference between peramivir and control groups for the primary endpoint was small." BioCryst received $234.8M from the federal Biomedical Advanced Research & Development Authority to help develop peramivir . The setback follows BioCryst last week withdrawing its IND application for its BCX5191 hepatitis C compound. (PR) [Healthcare, On the Move] Comment!
    Nov 8 11:12 AM | 4 Likes Like |Link to Comment
COMMENTS STATS
4,598 Comments
273 Likes